Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3290268
Max Phase: Preclinical
Molecular Formula: C22H35N3O5
Molecular Weight: 421.54
Molecule Type: Small molecule
Associated Items:
ID: ALA3290268
Max Phase: Preclinical
Molecular Formula: C22H35N3O5
Molecular Weight: 421.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)CCO[C@@H]1C=CC(=O)[C@@H](Cn2cc(CCCCOC(=O)C(C)(C)C)nn2)O1
Standard InChI: InChI=1S/C22H35N3O5/c1-16(2)11-13-28-20-10-9-18(26)19(30-20)15-25-14-17(23-24-25)8-6-7-12-29-21(27)22(3,4)5/h9-10,14,16,19-20H,6-8,11-13,15H2,1-5H3/t19-,20+/m1/s1
Standard InChI Key: VQESVGRHEQCINM-UXHICEINSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 421.54 | Molecular Weight (Monoisotopic): 421.2577 | AlogP: 3.10 | #Rotatable Bonds: 11 |
Polar Surface Area: 92.54 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.56 | CX LogP: 4.79 | CX LogD: 4.79 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.40 | Np Likeness Score: -0.15 |
1. Sharma S, Saquib M, Verma S, Mishra NN, Shukla PK, Srivastava R, Prabhakar YS, Shaw AK.. (2014) Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents., 83 [PMID:24992075] [10.1016/j.ejmech.2014.06.048] |
Source(1):